Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial

BACKGROUND: Recent consensus guidelines recommend pregabalin as a first-tier treatment for painful diabetic peripheral neuropathy (DPN). We evaluated the efficacy of pregabalin 600 mg/d (300 mg dosed BID) versus placebo for relieving DPN-associated neuropathic pain, and assessed its safety using obj...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Arezzo, Joseph C, Rosenstock, Julio, LaMoreaux, Linda, Pauer, Lynne
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2008
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2565674/
https://ncbi.nlm.nih.gov/pubmed/18796160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-8-33
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky